Back

Long-term outcomes of beta-blockers in post-MI patients with mildly reduced or preserved left ventricular ejection fraction: a systematic review and meta-analysis

30 August 2026 (10:15 - 10:45)
Organised by: Logo
Congress Presentation Part of: New advancements in targeting atherogenic lipoproteins Beta-Blockers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Kaveh Hosseini

Herlev and Gentofte Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail
Inclisiran in combination with statin therapy achieves profound LDL-C and lipoprotein(a) reduction without acute cardiovascular events in high-risk patients with familial hypercholesterolemia
Doctor K. Dyankov (Sofia, BG)
Abstract Slides
Presentation thumbnail
Preclinical study and evaluation of S016, a novel oral small-molecule PCSK9 inhibitor
Doctor G. Cen (Chengdu - Sichuan, CN)
Abstract Slides
Presentation thumbnail
Efficacy of PCSK9 inhibitors in patients with peripheral artery disease: insights from the AT-TARGET-IT Registry
Doctor M. Di Santo (Naples, IT)
Abstract Slides
Presentation thumbnail
Apolipoprotein C-III inhibition reduces acute pancreatitis in familial chylomicronemia syndrome: a meta-analysis of randomized trials
Doctor K. Mahajan (Mandi, IN)

Access the full session

Session thumbnail
New advancements in targeting atherogenic lipoproteins

The Event

Event poster

ESC Congress 2026

30 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
The need and duration of BB therapy in post MI patients with preserved left ventricular ejection fraction: a meta-analysis
27 August 2021
thumbnail
Congress Presentation
Long-term prognostic value of stress echocardiography in patients with suspected coronary artery disease - Systematic review and meta-analysis
12 May 2023
thumbnail
Congress Presentation
Outcomes of heart failure with mildly reduced or preserved ejection fraction during acute myocardial infarction admission compared to no heart failure group with reduced ejection fraction
20 May 2023
thumbnail
Congress Presentation
Effectiveness of bisoprolol versus selective beta-1 blockers in the management of hypertension: a systematic review and meta-analysis of randomized cross-over trials
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources